| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $25.5B | $23.6B | $24.9B | $24.4B | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $3.1B | $4.4B | $1.6B | $0.5B | — |
| Net Income | $2.3B | $3.7B | $1.6B | $-0.2B | — |
| EPS (Basic) | $7.40 | $11.91 | $5.02 | $-0.49 | — |
| EPS (Diluted) | $7.40 | $11.89 | $5.01 | $-0.49 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $57.2B | $52.9B | $50.8B | $46.9B | — |
| Current Assets | $12.1B | $10.8B | $8.3B | $9.4B | — |
| Cash & Equivalents | $3.6B | $3.0B | $0.4B | $0.4B | — |
| Total Liabilities | $42.4B | $39.4B | $39.5B | $35.5B | — |
| Current Liabilities | $7.9B | $6.8B | $6.3B | $7.8B | — |
| Stockholders' Equity | $14.5B | $13.2B | $10.9B | $11.0B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.2B | $-2.5B | $-5.3B | $-2.4B | — |
| Investing Cash Flow | $-3.2B | $7.4B | $3.0B | $3.1B | — |
| Capital Expenditures | $2.9B | $2.6B | $2.4B | $1.7B | — |
| Financing Cash Flow | $-0.4B | $-2.3B | $2.2B | $-0.8B | — |